Abstract
“Then Dr Strauss said Charlie even if this fales your making a grate contribyushun to sience. This experimint has been successful on lots of animals but its never bin tried on a humen being. You will be the first. After the operashun Im gonna try to be smart. Im gonna try awful hard.” (sic) p. 8, Flowers For Angernon [1]
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Keyes D (1959) Flowers for Algernon. New York: Bantam Books
Koob GF (1987) Neuropeptides and memory. In: LL Iversen, SD Iversen (eds): Handbook of Psychopharmacology, Plenum, New York, 531–573
White NM, Salinas JA (1998) Pharmacology approaches to the study of learning and memory. In:.JL Martinez Jr, R Kesner (eds): Neurobiology of learning and memory,Academic Press, San Diego, 143–176
Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NPV, Thakur M, McEwen BS, Hauger RL, Meaney Mt (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neurosci 1(1): 69–73
Martinez JL Jr, Schulteis G, Weinberger SB (1991) How to increase and decrease the strength of memory traces: The effects of drugs and hormones. In: JLj Martinez, RP Kesner (eds): Learning and memory: A biological view, Academic Press: New York, 149–198
Squire LR, Davis HP (1981) The pharmacology of memory: A neurobiological perspective. Ann Rev Pharmacol Toxicol 21(323): 323–356
Martinez JLj (1986) Memory: Drugs and hormones. In: JLj Martinez, RP Kesner (eds): Learning and memory: A biological view, Academic Press: New York
Krieger DT (1983) Brain peptides: What, where, and why? Science 222 (4627): 975–985
Martinez JL Jr, Jensen RA, McGaugh JL (1981) Attenuation of experimentally-induced amnesia. Prog Neurobiol 16(2): 155–186
Martinez JL Jr, Jensen RA, McGaugh JL (1983) Facilitation of memory consolidation. In: JA Deutsch (ed.): The Physiological Basis of Memory. Academic Press, New York, 49–70
Ettenberg A, Van der Kooy D, Le Moal M, Koob GF, Bloom FE (1983) Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory. Behav Brain Res 7: 331–350
Koob GF (1987) Learning and Memory: Principles and findings with a focus on vasopressin. Durham, North Carolina
Sahgal A (1984) A critique of the vasopressin-memory hypothesis. Psychopharmacol (Berl) 83(3): 215–228
Squire LR (1987) Memory and Brain. Oxford: Oxford University Press
Martinez JL Jr, Derrick BE (1996) Long-term potentiation and learning. Annu Rev Psychol 47: 173–203
Silva AJ (2003) Molecular and cellular cognitive studies of the role of synaptic plasticity in memory. J Neurobiol 54(1): 224–237
Meisenberg G, Simmons WH (1983) Centrally mediated effects of neurohypophyscal hormones. Neurosci Biobehav Rev 7(2): 263–280
Dantzer R, Bluthe RM (1992) Vasopressin involvement in antipyresis, social communication, and social recognition: A synthesis. Crit Rev Neurobiol 6(4): 243–255
Dantzer R (1998) Vasopressin, gonadal steroids and social recognition. Frog Brain Res 119: 409–414
De Wied D (1984) The importance of vasopressin in memory. Trends in Neuroscience 7(62): 62–64
Mishima K, Tsukikawa H, Inada K, Fujii M, Iwasaki K, Matsumoto Y, Abe K, Egawa T, Fujiwara M (2001) Ameliorative effect of vasopressin-(4–9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze. Eur J Pharmacol 427(1): 43–52
Taga C, Sugimoto Y, Nishiga M, Fujii Y, Kamei C (2001) Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats. Eur J Pharmacol 423(2–3): 167–170
Tanabe S, Shishido Y, Nakayama Y, Furushiro M, Hashimoto S, Terasaki T, Tsujimoto G, Yokokura T (1999) Effects of arginine-vasopressin fragment 4–9 on rodent cholinergic systems. Pharmacol Biochem Behav 63(4): 549–553
Dietrich A, Taylor JT, Passmore CE (2001) AVP (4–8) improves concept learning in PFC-damaged but not hippocampal-damaged rats. Brain Res 919(1): 41–47
Hori E, Uwano T, Tamura R, Miyake N, Nishijo H, Ono T (2002) Effects of a novel arginine-vasopressin derivative, NC-1900, on the spatial memory impairment of rats with transient forebrain ischemia. Brain Res Copt Brain Res 13(1): 1–15
Jolles J (1983) Vasopressin-like peptides and the treatment of memory disorders in man. Prog Brain Res 60: 169–182
Boccia MM, Baratti CM (2000) Involvement of central cholinergic mechanisms in the effects of oxytocin and an oxytocin receptor antagonist on retention performance in mice. Neurobiol Learn Mem 74(3): 217–228
Ferguson JN, Young L.J, Insel TR (2002) The neuroendocrine basis of social recognition. Front Neuroendocrinol 23(2): 200–224
Young LJ (2002) The neurobiology of social recognition, approach, and avoidance. Biol Psychiatry 51(1): 18–26
Ferguson JN, Young LJ, Insel TR (2002) The neuroendocrine basis of social recognition. Front Neuroendocrinol 23(2): 200–224
Frick KM, Price DL, Koliatsos VE, Markowska AL (1997) The effects of nerve growth factor on spatial recent memory in aged rats persist after discontinuation of treatment. J Neurosci 17(7): 2543–2550
Markowska AL, Price D, Koliatsos VE (1996) Selective effects of nerve growth factor on spatial recent memory as assessed by a delayed nonmatching-to-position task in the water maze. J Neurosci 16(10): 3541–3548
Chen KS, Masliah E, Mallory M, Gage FH (1995) Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion. Neurosci 68(1): 19–27
Lukoyanov NV, Pereira PA, Paula-Barbosa MM, Cadete-Leite A (2003) Nerve growth factor improves spatial learning and restores hippocampal cholinergic fibers in rats withdrawn from chronic treatment with ethanol. Exp Brain Res 148(1): 88–94
Gustilo MC, Markowska AL, Breckler SJ, Fleischman CA, Price DL, Koliatsos VE (1999) Evidence that nerve growth factor influences recent memory through structural changes in septohippocampal cholinergic neurons. J Comp Neurol 405(4): 491–507
Fischer W, Sirevaag A, Wiegand SJ, Lindsay RM, Bjorklund A (1994) Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc Natl Acad Sci USA 91(18): 8607–8611
Woolf NJ, Milov AM, Schweitzer ES, Roghani A (2001) Elevation of nerve growth factor and antisense knockdown of TrkA receptor during contextual memory consolidation. J Neurosci 21(3): 1047–1055
Fiore M, Triaca V, Amendola T, Tirassa P, Aloe L (2002) Brain NGF and EGF administration improves passive avoidance response and stimulates brain precursor cells in aged male mice. Physiol Behav 77(2–3): 437–443
Calamandrei G, Valanzano A, Ricceri L (2002) NGF induces appearance of adult-like response to spatial novelty in 18-day male mice. Behav Brain Res 136(1): 289–298
Koliatsos VE, Clatterbuck RE, Nauta HJ, Knusel B, Burton LE, Hefti FF, Mobley WC, Price DL (1991) Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 30(6): 831–840
Smith DE, Roberts J, Gage FH, Tuszynski MH (1999) Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci USA 96(19): 10893–10898
Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD (2002) From acquisition to consolidation: On the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 9(5): 224–237
Yamada K, Mizuno M, Nabeshima T (2002) Role for brain-derived neurotrophic factor in learning and memory. Life Sci 70(7): 735–744
Croll SD, Ip NY, Lindsay RM, Wiegand SJ (1998) Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res 812(1–2): 200–208
Schaaf MJ, Workel JO, Lesscher HM, Vreugdenhil E, Oitzl MS, de Kloet ER (2001) Correlation between hippocampal BDNF mRNA expression and memory performance in senescent rats. Brain Res 915(2): 227–233
Tokuyama W, Okuno H, Hashimoto T, Xin Li Y, Miyashita Y (2000) BDNF up-regulation during declarative memory formation in monkey inferior temporal cortex. Nature Neurosci 3(11): 1134–1142
Johnston AN, Rose SP (2001) Memory consolidation in day-old chicks requires BDNF but not NGF or NT-3; an antisense study. Brain Res Mol Brain Res 88(1–2): 26–36
Takei N, Kuramoto H, Endo Y, Hatanaka H (1997) NGF and BDNF increase the immunoreactivity of vesicular acetylcholine transporter in cultured neurons from the embryonic rat septum. Neurosci Lett 226(3): 207–209
Heinrichs SC (1999) Stress-axis, coping and dementia: gene-manipulation studies. Trends in Pharmacol Sci 20: 311–315
Luine VN, Spencer RL, McEwen BS (1993) Effects of chronic corticosterone ingestion on spatial memory performance and hippocampal serotonergic function. Brain Res 616: 65–70
Gold PE, van Buskirk R (1976) Enhancement and impairment of memory processes with post-trial injections of adrenocorticotrophic hormone. Behav Biol 16: 387–400
Ohl F, Fuchs E (1999) Differential effects of chronic stress on memory processes in the tree shrew. Brain Res Cogn Brain Res 7(3): 379–387
Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996) Stress-and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58(17): 1475–1483
De Wied D, Jolles J (1982) Neuropeptides derived from pro-opiocortin: Behavioral, physiological and neurochemical effects. Physiol Rev 62: 976–1059
Kumar KB, Karanth KS (1996) Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats. J Neural Transm 103: 1117–1126
McGaugh JL (1989) Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Ann Rev Neurosci 12: 255–287
Dachir S, Kadar T, Robinzon B, Levy A (1993) Cognitive deficits induced in young rats by longterm corticosterone administration. Behav Neural Biol 60: 103–109
Martinez JL Jr, Jensen RA, Messing RB, Rigter H, McGaugh JL (1981) Endogenous Peptides and Learning and Memory Processes. In: JL McGaugh, JC Fentress, JP Hegmann (eds): Behavioral Biology: An International Series, Academic Press, New York
Gaillard AW, Varey CA (1979) Some effects of an ACTH 4–9 analog (Org 2766) on human performance. Physiol Behav 23(1): 79–84
Heinrichs SC, De Souza EB (2001) Corticotropin-releasing factor in brain: Executive gating of neuroendocrine and functional outflow. In: BS McEwen (ed.): Handbook of Physiology. Oxford University Press, New York, 125–137
Akwa Y, Purdy RH, Koob GF, Britton KT (1999) The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 106(1–2): 119–125
Sahgal A, Wright C, Edwardson JA, Keith AB (1983) Corticotrophin releasing factor is more potent than some corticotrophin-related peptides in affecting passive avoidance behaviour in rats. Neurosci Lett 36: 81–86
Deffenbacher KA (1983) The influence of arousal on reliability of testimony, Chapter 13. In: SMA Lloyd-Bostock, BR Clifford (eds): Evaluating Witness Evidence. John Wiley and Sons Ltd., New York, 235–249
Honour LC, White MH (1988) Pre-and postnatally administered ACTH, Organon 2766 and CRF facilitate or inhibit active avoidance task performance in young adult mice. Peptides 9(4): 745–750
De Wied D, Bohus B (1979) Modulation of memory processes by neuropeptides of hypothalamic-neurohypophyseal origin. Raven Press,New York (139): 139–149
Contarino A, Heinrichs SC, Gold LH (1999) Understanding CRF neurobiology: contribution from mutant mice. Neuropeptides 33: 1–12
Steckler T, Holsboer F (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46(11): 1480–1508
Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong M-L, Chrousos GP, Webster E et al. (1999) The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140(1): 79–86
Eckart K, Radulovic J, Radulovic M, Jahn O, Blank T, Stiedl O, Spiess J (1999) Actions of CRF and its analogs. Current Medicinal Chemistry 6(11): 1035–1053
Zorrilla EP, Schulteis G, Ling N, Koob GF, De Souza EB (2001) Performance enhancing effects of CRF-BP ligand inhibitors. Neuroreport 12: 1231–1234
Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW (1995) Corticotropin releasing factor (CRF) binding protein: A novel regulator of CRF and related peptides. Front Neuroendocrinol 16: 362–382
Heinrichs SC, Lapsansky J, Lovenberg TW, De Souza EB, Chalmers DT (1997) Corticotropinreleasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regulatory Peptides 71: 15–21
Bonaz B, Rivest S (1998) Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. American J Physiology 275(5 PART 2): R1438–R1449
Wang HL, Wayner MJ, Chai CY, Lee EHY (1998) Corticotropin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur J Neurosci 10: 3428–3437
Fuchs E, Fltigge G, Ohl F, Lucassen P, Vollmann-Honsdorf GK, Michaelis TM (2001) Psychosocial stress, glucocorticoids, and the structural alterations in the tree shrew hippocampus. Physiol Behav 73: 285–291
Buggy J, Hewitt CD, Kemeny G, Davis JM, Stock H, Hand GA (1999) Hypothalamic and amygdalar corticotropin-releasing factor (CRF) after fatiguing exercise. Society for Neuroscience Abstracts 25(1–2): 63
De Souza E, Whitehouse PJ, Kuhar MJ, Price DL, Vale W (1986) Reciprocal changes in corticotropin-releasing factor (CRF)-like Alzheimer’s disease. Nature 319(593): 593–595
Wright JW, Harding JW (1995) Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul Pept 59(3): 269–295
Wright JW, Harding JW (1997) Important role for angiotensin III and IV in the brain reninangiotensin system. Brain Res Rev 25(1): 96–124
Gard PR (2002) The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 438(1–2): 1–14
Karwowska-Polecka W, Kulakowska A, Wisniewski K, Braszko JJ (1997) Losartan influences behavioural effects of angiotensin 11(3–7) in rats. Pharmacol Res 36(4): 275–283
Tchekalarova J, Kambourova T, Georgiev V (2002) Interaction of angiotensin II and III with adenosine A(1) receptor-related drugs in passive avoidance conditioning in rats. Behav Brain Res 129(1–2): 61–64
Wright JW, Stubley L, Pederson ES, Kramar EA, Hanesworth JM, Harding JW (1999) Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J Neurosci 19(10): 3952–3961
Lee J, Chai SY, Mendelsohn FA, Morris MT Allen AM (2001) Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacol 40(4): 618–623
Chai SY, Bastias MA, Clune EF, Matsacos DJ, Mustafa T, Lee JH, McDowall SG, Paxinos G, Mendelsohn FA, Albiston AL (2000) Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography. J Chem Neuroanat 20(3–4): 339–348
Barnes JM, Barnes NM, Costall B, Horovitz ZP, Ironside JW, Naylor RJ, Williams TJ (1990) Angiotensin II inhibits acetylcholine release from human temporal cortex: Implications for cognition. Brain Res 507(2): 341–343
Barnes JM, Barnes NM, Costall B, Horovitz ZP, Ironside JW, Naylor RJ, Williams TJ (1990) Angiotensin II inhibits cortical cholinergic function: Implications for cognition. J Cardiovasc Pharmacol 16(2): 234–238
Voits M, Hasenohrl RU, Huston JP, Fink H (2001) Repeated treatment with cholecystokinin octapeptide improves maze performance in aged Fischer 344 rats. Peptides 22(8): 1325–1330
Katsuura G, Itoh S (1986) Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats. Peptides 7(5): 809–814
Itoh S, Takashima A, Igano K, Inouye K (1989) Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat. Peptides 10(4): 843–848
Itoh S, Takashima A, Katsuura G (1988) Effect of cholecystokinin tetrapeptide amide on the metabolism of 5-hydroxytryptamine in the rat brain. Neuropharmacol 27(4): 427–431
Takashima M, Katoh Y, Takeuchi Y, Takahashi K (1991) Effect of subchronic administration of methylcobalamin on the acetylcholine and choline content in the brain and locomotor activity in rats. Jpn J Psychiatry Neurol 45(1): 173–175
Itoh S, Takashima A, Maeda Y (1992) Protective effect of cerulein on memory impairment induced by protein synthesis inhibitors in rats. Peptides 13(5): 1007–1012
Nomoto S, Miyake M, Ohta M, Funakoshi A, Miyasaka K (1999) Impaired learning and memory in OLETF rats without cholecystokinin (CCK)-A receptor. Physiol Behav 66(5): 869–872
Lena I, Simon H, Rogues BP, Dauge V (1999) Opposing effects of two CCK(B) agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat. Neuropharmacol 38(4): 543–553
Lena I, Dh tel H, Garbay C, Dauge V (2001) Involvement of D2 dopamine receptors in the opposing effects of two CCK-B agonists in a spatial recognition memory task: Role of the anterior nucleus accumbens. Psychopharmacol 153(2): 170–179
Sebret A, Lena I, Crete D, Matsui T, Rogues BP, Dauge V (1999) Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation. J Neurosci 19(16): 7230–7237
Taghzouti K, Lena I, Dellu F, Rogues BP, Dauge V, Simon H (1999) Cognitive enhancing effects in young and old rats of pBC264, a selective CCK(B) receptor agonist. Psychopharmacol 143(2): 141–149
Weller A, Tsitolovskya L, Gispan IH, Rabinovitz S (2001) Examining the role of cholecystokinin in appetitive learning in the infant rat. Peptides 22(8): 1317–1323
Derrien M, Dauge V, Blommaert A, Rogues BP (1994) The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats. Behav Brain Res 65(2): 139–146
Tirassa P, Stenfors C, Lundeberg T, Aloe L (1998) Cholecystokinin-8 regulation of NGF con-centrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors. Br J Pharmacol 123(6): 1230–1236
Tirassa P, Aloe L, Stenfors C, Turrini P, Lundebcrg T (1999) Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis. Proc Natl Acad Sci USA 96(11): 6473–6477
Sugaya K, Takahashi M, Kubota K (1992) Cholecystokinin protects cholinergic neurons against basal forebrain lesion. Jpn J Pharmacol 59(1): 125–128
Robinson JK, Crawley JN (1994) Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats. Behav Neurosci 108(5): 941–950
Crawley JN (1993) Functional interactions of galanin and acetylcholine: Relevance to memory and Alzheimer’s disease. Behav Brain Res 57(2): 133–141
Sundstrom E, Archer T, Melander T, Hokfelt T (1988) Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neurosci Lett 88(3): 331–335
Ogren SO, Kehr J, Schott PA (1996) Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat. Neuroscience 75(4): 1127–1140
Ogren SO, Schott PA, Kehr J, Misane I, Razani H (1999) Galanin and learning. Brain Res 848(1–2): 174–182
Thorsell A, Heilig M (2002) Diverse functions of neuropeptide Y revealed using genetically modified animals. Neuropeptides 36(2–3): 182–193
Caberlotto L, Fuxe K, Rimland TM, Sedvall G, Hurd YL (1998) Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain. Neuroscience 86(1): 167–178
Dumont Y, Jacques D, Bouchard P, Quirion R (1998) Species differences in the expression and distribution of the neuropeptide Y Yl, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol 402(3): 372–384
Gustafson EL, Smith KE, Durkin MM, Walker MW, Gerald C, Weinshank R, Branchek TA (1997) Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system. Brain Res Mol Brain Res 46(1–2): 223–235
Morley JE, Flood JF (1990) Neuropeptide Y and memory processing. Ann N Y Acad Sci 611: 226–231
Bouchard P, Maurice T, St-Pierre S, Privat A, Quirion R (1997) Neuropeptide Y and the calcitonin gene-related peptide attenuate learning impairments induced by MK-801 via a sigma receptor-related mechanism. Eur J Neurosci 9(10): 2142–2151
Parker E, Van Heek M, Stamford A (2002) Neuropeptide Y receptors as targets for anti-obesity drug development: Perspective and current status. Eur J Pharmacol 440(2–3): 173–187
Redrobe JP, Dumont Y, St-Pierre JA, Quirion R (1999) Multiple receptors for neuropeptide Y in the hippocampus: Putative roles in seizures and cognition. Brain Res 848(1–2): 153–166
Sheikh SP, Feldthus N, Orkild H, Goke R, McGregor GP, Turner D, Moller M, Stuenkel EL (1998) Neuropeptide Y2 receptors on nerve endings from the rat neurohypophysis regulate vasopressin and oxytocin release. Neuroscience 82(1): 107–115
Silva AP, Cavadas C, Grouzmann E (2002) Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326(1–2): 3–25
Pasternak GW (1988) Studies of multiple morphine and enkephalin receptors: Evidence for mul receptors. Adv Exp Med Biol 236: 81–93
Pasternak GW (1988) Multiple morphine and enkephalin receptors and the relief of pain. JAMA 259(9): 1362–1367
Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker TM (1984) Endogenous opioids: Biology and function. Annu Rev Neurosci 7: 223–255
Martinez JL Jr, Olson K, Hilston C (1984) Opposite effects of Met-enkephalin and Leuenkephalin on a discriminated shock-escape task. Behav Neurosci 98(3): 487–495
Izquierdo I, Dias RD, Souza DO, Carrasco MA, Elisabetsky E, Perry ML (1980) The role of opioid peptides in memory and learning. Behav Brain Res 1(6): 451–468
Izquierdo I, Dias RD (1981) Retrograde amnesia caused by Met-, Leu-and des-Try-Metenkephalin in the rat and its reversal by naloxone. Neurosci Lett 22(2): 189–193
Colombo PJ, Thompson KR, Martinez JL Jr, Bennett EL, Rosenzweig MR (1993) Dynorphin(1–13) impairs memory formation for aversive and appetitive learning in chicks. Peptides 14(6): 1165–1170
Colombo PJ, Martinez JL Jr, Bennett EL, Rosenzweig MR (1992) Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick. Psychopharmacology (Berl) 108(1–2): 235–240
Sandin J, Nylander I, Georgieva J, Schott PA, Ogren SO, Terenius L (1998) Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect. Neuroscience 85(2): 375–382
Jiang HK, Owyang VV, Hong JS, Gallagher M (1989) Elevated dynorphin in the hippocampal formation of aged rats: Relation to cognitive impairment on a spatial learning task. Proc Nati Acad Sci USA 86(8): 2948–2951
Farr SA, Banks WA, Morley JE (2000) Estradiol potentiates acetylcholine and glutamate-mediated post-trial memory processing in the hippocampus. Brain Res 864(2): 263–269
Gibbs RB (1999) Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm Behav 36(3): 222–233
Heikkinen T, Puolivali J, Liu L, Rissanen A, Tanila H (2002) Effects of ovariectomy and estrogen treatment on learning and hippocampal neurotransmitters in mice. Horm Behav 41(1): 22–32
Daniel JM, Dohanich GP (2001) Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA 1 of the hippocampus and the associated improvement in working memory. J Neurosci 21(17): 6949–6956
Fugger HN, Foster TC, Gustafsson J, Rissman EF (2000) Novel effects of estradiol and estrogen receptor alpha and beta on cognitive function. Brain Res 883(2): 258–264
Rissman EF, Heck AL, Leonard JE, Shupnik MA, Gustafsson JA (2002) Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc Nati Acad Sci USA 99(6): 3996–4001
Woolley CS, Gould E, Frankfurt M, McEwen BS (1990) Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 10(12): 4035–4039
McEwen B (2002) Estrogen actions throughout the brain. Recent Progress in Hormone Research 57: 357–384
Horvath KM, Hartig W, Van der Veen R, Keijser JN, Mulder J, Ziegert M, Van der Zee EA, Harkany T, Luiten PG (2002) 17beta-estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis. Neuroscience 110(3): 489–504
Frick KM, Fernandez SM, Bulinski SC (2002) Estrogen replacement improves spatial reference memory and increases hippocampal synaptophysin in aged female mice. Neuroscience 115(2): 547–558
Resnick SM, Maki PM (2001) Effects of hormone replacement therapy on cognitive and brain aging. Ann N Y Acad Sci 949: 203–214
Zec RF, Trivedi MA (2002) The effects of estrogen replacement therapy on neuropsychological functioning in post-menopausal women with and without dementia: A critical and theoretical review. Neuropsychol Rev 12(2): 65–109
Baulieu EE, Robel P, Schumacher M (2001) Neurosteroids: Beginning of the story. Int Rev Neurobiol 46: 1–32
Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6: 2311–2311
Bergeron R, de Montigny C, Debonnel G (1996) Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: Effects mediated via sigma receptors. J Neurosci 16(3): 1193–1202
Maurice T, Junien JL, Privat A (1997) Dehydroepiandrosterone sulfate attenuates dizocilpineinduced learning impairment in mice via sigma 1-receptors. Behav Brain Res 83(1–2): 159–164
Darnaudery M, Koehl M, Piazza PV, Le Moal M, Mayo W (2000) Pregnenolone sulfate increases hippocampal acetylcholine release and spatial recognition. Brain Res 852(1): 173–179
Pallares M, Darnaudery M, Day J, Le Moal M, Mayo W (1998) The neurosteroid pregnenolone sulfate infused into the nucleus basalis increases both acetylcholine release in the frontal cortex or amygdala and spatial memory. Neuroscience 87(3): 551–558
Akwa Y, Ladurelle N, Covey DF, Baulieu EE (2001) The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms? Proc Nati Acad Sci USA 98(24): 14033–14037
Mathis C, Vogel E, Cagniard B, Criscuolo F, Ungerer A (1996) The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice. Neuropharmacology 35(8): 1057–1064
Meziane H, Mathis C, Paul SM, Ungerer A (1996) The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task. Psychopharmacology 126(4): 323–330
Reddy DS, Kulkarni SK (1998) The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res 791(1–2): 108–116
Vallee M, Mayo W, Darnaudery M, Corpechot C, Young J, Koehl M, Le Moal M, Baulieu EE, Robel P, Simon H (1997) Neurosteroids: Deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci USA 94(26): 14865–14870
Mayo W, Le Moal M, Abrous DN (2001) Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, and morphological investigations. Horm Behav 40(2): 215–217
Vallee M, Mayo W, Koob GF, Le Moal M (2001) Neurosteroids in learning and memory processes. Int Rev Neurobiol 46: 273–320
Bowlby MR (1993) Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol Pharmacol 43: 813–819
Majewska MD, Bluet, Pajot M. T, Robel P, Baulieu EE (1989) Pregnenolone sulfate antagonizes barbituate-induced hypnosis. Pharmacol Biochem Behav 33(701): 701–703
Nilsson KR, Zorumski CF, Covey DF (1998) Neurosteroid analogues. 6. The synthesis and GABAA receptor pharmacology of enantiomers of dehydroepiandrosterone sulfate, pregnenolone sulfate, and (3alpha,5beta)-3-hydroxypregnan-20-one sulfate. J Med Chem 41(14): 2604–2613
Martignoni E, Costa A, Sinforiani E, Liuzzi A, Chiodini P, Mauri M, Bono G, Nappi G (1992) The brain as a target for adrenocortical steroids: Cognitive implications. Psychoneuoroendocrinol 17: 343–354
de Kloet ER, Grootendorst J, Karssen AM, Oitzl MS (2002) Gene x environment interaction and cognitive performance: animal studies on the role of corticosterone. Neurobiol Learn Mem 78(3): 570–577
Sapolsky RM (1993) Potential behavioral modification of glucocorticoid damage to the hippocampus. Behav Brain Res 57: 175–182
Oitzl MS, de Kloet ER (1992) Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav Neurosci 106(1): 62–71
Sandi C, Rose SPR (1994) Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm. Brain Res 647: 106–112
de Quervain DJ, Roozendaal B, McGaugh JL (1998) Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394: 787–790
McGaugh JL, Roozendaal B (2002) Role of adrenal stress hormones in forming lasting memories in the brain. Curr Opin Neurobiol 12(2): 205–210
Buchanan TW, Lovallo WR (2001) Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 26(3): 307–317
Porter NM, Landfield PW (1998) Stress hormones and brain aging: Adding injury to insult. Nature Neuroscience 1(1): 3–4
McEwen BS (1997) Possible mechanisms for atrophy of the human hippocampus. Molecular Psychiatry 2: 255–262
Heinrichs SC, Joppa M (2001) Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats. Behav Brain Res 122: 43–50
Heinrichs SC, Vale EA, Lapsansky J, Behan DP, McClure LV, Ling N, De Souza EB, Schulteis G (1997) Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Peptides 18(5): 711–716
Martinez JL Jr, Janak PH, Weinberger SB, Schulteis G, Derrick BE (1990) Enkephalin influences on behavioral and neural plasticity: Mechanisms of action. NIDA Res Monogr 97: 48–78
Bliss TV, Collingridge GL (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361(6407): 31–39
Gibbs DM (1984) Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress. Life Sci 35(5): 487–491
Buijs RM (1983) Vasopressin and oxytocin—their role in neurotransmission. Pharmacol Ther 22(1): 127–141
Buijs RM, De Vries GJ, Van Leeuwen FW, Swaab DF (1983) Vasopressin and oxytocin: Distribution and putative functions in the brain. Prog Brain Res 60: 115–122
Chepkova AN, Kapai NA, Skrebitskii VG (2001) Arginine vasopressin fragment AVP(4–9) facilitates induction of long-term potentiation in the hippocampus. Bull Exp Biol Med 131(2): 136–138
Dubrovsky B, Tatarinov A, Gijsbers K, Harris J, Tsiodras A (2003) Effects of arginine-vasopressin (AVP) on long-term potentiation in intact anesthetized rats. Brain Res Bull 59(6): 467–472
Chen C, Diaz Brinton RD, Shors TJ, Thompson RF (1993) Vasopressin induction of long-lasting potentiation of synaptic transmission in the dentate gyrus. Hippocampus 3(2): 193–203
Kinsley CH, Madonia L, Gifford GW, Tureski K, Griffin GR, Lowry C, Williams J, Collins J, McLearie H, Lambert KG (1999) Motherhood improves learning and memory. Nature 402(6758): 137–138
Tomizawa K, Iga N, Lu YE, Moriwaki A, Matsushita M, Li ST, Miyamoto O, Itano T, Matsui H (2003) Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci 6(4): 384–390
Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Nati Acad Sci USA 92(19): 8856–8860
Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16(6): 1137–1145
Gooney M, Shaw K, Kelly A, O’Mara SM, Lynch MA (2002) Long-term potentiation and spatial learning are associated with increased phosphorylation of TrkB and extracellular signal-regulated kinase (ERK) in the dentate gyrus: Evidence for a role for brain-derived neurotrophic factor. Behav Neurosci 116(3): 455–463
Messaoudi E, Ying SW, Kanhema T, Croll SD, Bramham CR (2002) Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 22(17): 7453–7461
Kovalchuk Y, Hanse E, Kafitz KW, Konnerth A (2002) Postsynaptic Induction of BDNFMediated Long-Term Potentiation. Science 295(5560): 1729–1734
Mizuno M, Yamada K, He J, Nakajima A, Nabeshima T (2003) Involvement of BDNF receptor TrkB in spatial memory formation. Learn Mem 10(2): 108–115
Buwalda B, de Boer SF, Van Kalkeren AA, Koolhaas JM (1997) Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 22(5): 297–309
Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L (1995) Suppression of corticotropinreleasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6(1): 74–80
Heinrichs SC, Menzaghi F, Merlo Pich E, Britton KT, Koob GF (1995) The role of CRF in behavioral aspects of stress. Ann N Y Acad Sci 771: 92–104
Wang HL, Tsai LY, Lee EH (2000) Corticotropin-releasing factor produces a protein synthesis—dependent long-lasting potentiation in dentate gyms neurons. J Neurophysiol 83(1): 343–349
Wang HL, Wayner MJ, Chai CY, Lee EH (1998) Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur J Neurosci 10(11): 3428–3437
Rebaudo R, Melani R, Balestrino M, Izvarina N (2001) Electrophysiological effects of sustained delivery of CRF and its receptor agonists in hippocampal slices. Brain Res 922(1): 112–117
Blank T, Nijholt I, Eckart K, Spiess J (2002) Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: Implications for hippocampusdependent learning. J Neurosci 22(9): 3788–3794
Kramar EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW (2001) The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res 897(1–2): 114–121
Wayner MJ, Armstrong DL, Phelix CF, Wright JW, Harding JW (2001) Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides 22(9): 1403–1414
Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361(6411): 453–457
Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Caen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368(6470): 419–424
Madani R, Hulo S, Toni N, Madani H, Steimer T, Muller D, Vassalli JD (1999) Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. Embo J 18(11): 3007–3012
Chen ZL, Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91(7): 917–925
Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, Jacquin M, Bu G (2000) Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 20(2): 542–549
Wright JW, Kramar EA, Meighan SE, Harding JW (2002) Extracellular matrix molecules, longterm potentiation, memory consolidation and the brain angiotensin system. Peptides 23(1): 221–246
Matsumoto A, Arai Y (1977) Precocious puberty and synaptogenesis in the hypothalamic arcuate nucleus in pregnant mare serum gonadotropin (PMSG) treated immature female rats. Brain Res 129(2): 375–378
Cordoba Montoya DA, Caner HF (1997) Estrogen facilitates induction of long-term potentiation in the hippocampus of awake rats. Brain Res 778(2): 430–438
Good M, Day M, Muir JL (1999) Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CAI region. Eur J Neurosci 11(12): 4476–4480
Singh M, Meyer EM, Millard WJ, Simpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644(2): 305–312
O’Neal MF, Means LW, Poole MC, Hamm RJ (1996) Estrogen affects performance of ovariectomized rats in a two-choice water-escape working memory task. Psychoneuroendocrinology 21(1): 51–65
Kim JS, Kim HY, Kim JH, Shin HK, Lee SH, Lee YS, Son H (2002) Enhancement of rat hippocampal long-term potentiation by 17 beta-estradiol involves mitogen-activated protein kinasedependent and -independent components. Neurosci Lett 332(1): 65–69
Gureviciene I, Puolivali J, Pussinen R, Wang J, Tanila H, Ylinen A (2003) Estrogen treatment alleviates NMDA-antagonist induced hippocampal LTP blockade and cognitive deficits in ovariectomized mice. Neurobiol Learn Mem 79(1): 72–80
Lisman J (1989) A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proc Natl Acad Sci USA 86(23): 9574–9578
Grant SG, O’Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER (1992) Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258(5090): 1903–1910
O’Meara G, Coumis U, Ma SY, Kehr J, Mahoney S, Bacon A, Allen SJ, Holmes F, Kahl U, Wang FH et al. (2000) Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci USA 97(21): 11569–11574
Crawley IN, Mufson EJ, Hohmann JG, Teklemichael D, Steiner RA, Holmberg K, Xu ZQ, Blakeman KH, Xu XJ, Wiesenfeld-Hallin Z et al. (2002) Galanin over-expressing transgenic mice. Neuropeptides 36(2–3): 145–156
Harris EW, Cotman CW (1986) Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl D-aspartate antagonists. Neurosci Lett 70(1): 132–137
Derrick BE, Martinez JL Jr (1994) Frequency-dependent associative long-term potentiation at the hippocampal mossy fiber-CA3 synapse. Proc Natl Acad Sci USA 91(22): 10290–10294
Derrick BE, Martinez JL Jr (1994) Opioid receptor activation is one factor underlying the frequency dependence of mossy fiber LTP induction. J Neurosci 14(7): 4359–4367
Derrick BE, Martinez JL Jr (1996) Associative, bidirectional modifications at the hippocampal mossy fibre-CA3 synapse. Nature 381(6581): 429–434
Derrick BE, Rodriguez SB, Lieberman DN, Martinez JL Jr (1992) Mu opioid receptors are associated with the induction of hippocampal mossy fiber long-term potentiation. J Pharmacol Exp Ther 263(2): 725–733
Derrick BE, Weinberger SB, Martinez JL Jr (1991) Opioid receptors are involved in an NMDA receptor-independent mechanism of LTP induction at hippocampal mossy fiber-CA3 synapses. Brain Res Bull 27(2): 219–223
Do VH, Martinez CO, Martinez JL Jr, Derrick BE (2002) Long-term potentiation in direct perforant path projections to the hippocampal CA3 region in vivo. J Neurophysiol 87(2): 669–678
Jin W, Chavkin C (1999) Mu opioids enhance mossy fiber synaptic transmission indirectly by reducing GABAB receptor activation. Brain Res 821(2): 286–293
Ying SW, Futter M, Rosenblum K, Webber MJ, Hunt SP, Bliss TV, Bramham CR (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: Requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 22(5): 1532–1540
Weisskopf MG, Zalutsky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362(6419): 423–427
Barea-Rodriguez EJ, Rivera DT, Jaffe DB, Martinez JL Jr (2000) Protein synthesis inhibition blocks the induction of mossy fiber long-term potentiation in vivo. J Neurosci 20(22): 8528–8532
Thompson KJ, Orfila JE, Archanta P, Martinez JJ (2003) submitted to Cell and Molecular Biology
Roberts LA, Large CH, O’ Shaughnessy CT, Morris BJ (1997) Long-term potentiation in perforant path/granule cell synapses is associated with a post-synaptic induction of proenkephalin gene expression. Neurosci Lett 227(3): 205–208
Whittaker E, Vereker E, Lynch MA (1999) Neuropeptide Y inhibits glutamate release and longterm potentiation in rat dentate gyrus. Brain Res 827(1–2): 229–233
Sarter M (1991) Taking stock of cognition enhancers. Trends Pharmacol Sci 12(12): 456–461
Korol DL (2002) Enhancing cognitive function across the life-span. Ann N Y Acad Sci 959: 167–179
Benton D (1990) The impact of increasing blood glucose on psychological functioning. Biol Psychol 30(1): 13–19
Pollitt E, Lewis NL, Garza C, Shulman RJ (1982) Fasting and cognitive function. J Psychiatr Res 17(2): 169–174
Gold PE, Stone WS (1988) Neuroendocrine effects on memory in aged rodents and humans. Neurobiol Aging 9(5–6): 709–717
Wenk GL (1989) An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers. Psychopharmacology (Berl) 99(4): 431–438
Lombardi WJ, Weingartner H (1995) Pharmacoloigcal treatment of impaired memory function. In: AD Baddeley, BA Wilson, FN Watts (eds): Handbook of Memory Disorders. Wiley, New York, 577–601
Olton DS, Wenk L (1990) The development of behavioral tests to assess the effects of cognitive enhancers. Pharmacopsychiatry 23 Suppl 2: 65–69
Cardinal RN, Parkinson JA, Hall J, Everitt BJ (2002) Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26(3): 321–352
Ochsner KN (2000) Are affective events richly recollected or simply familiar? The experience and process of recognizing feelings past. J Exp Psychol Gen 129(2): 242–261
Gold LH (1999) Hierarchical strategy for phenotypic analysis in mice. Psychopharmacology 147: 2–4
Crawley JN, Paylor R (1997) A proposed test battery and constellations of specific behavior paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones and Behavior 31: 197–211
Sarter M, Bruno JP, Givens B, Moore H, McGaughy J, McMahon K (1996) Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable. Brain Res Cogn Brain Res 3(3–4): 329–343
Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ (2002) Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA 99(21): 13908–13913
Behan DP, Heinrichs SC, Troncoso JC, Liu X-J, Kawas CH, Ling N, De Souza EB (1995) Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer’s disease. Nature 378: 284–287
Radulovic J, Fischer A, Katerkamp U, Spiess J (2000) Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning. Neuropharmacology. 39(4): 707–710
Bernardi F, Lanzone A, Cento RM, Spada RS, Pezzani I, Genazzani AD, Luisi S, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer’s disease and vascular dementia. European J Endocrinology 142(5): 466–471
Behan DP, Grigoriadis DE, Lovenberg T, Chalmers D, Heinrichs S, Liaw C, De Souza EB (1996) Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: Implications for the treatment of CNS disorders. Molecular Psychiatry 1: 265–277
Thornton PL, Ingram RL, Sonntag WE (2000) Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. J Gerontol A Biol Sci Med Sci 55(2): B106–112
Shanley LI, Irving AJ, Harvey J (2001) Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci 21(24): RC186
Li XL, Aou S, Oomura Y, Hon N, Fukunaga K, Hon T (2002) Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113(3): 607–615
Hiramatsu M, Inoue K (2000) Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory. European J Pharmacology 395(2): 149–156
Telegdy G, Adamik A (2002) The action of orexin A on passive avoidance learning. Involvement of transmitters. Regulatory Peptides 104(1–3): 105–110
Jaeger LB, Farr SA, Banks WA, Morley JE (2002) Effects of orexin-A on memory processing. Peptides 23(9): 1683–1688
Lenard L, Kertes E (2002) Influence of passive avoidance learning by substance P in the basolateral amygdala. Acta Biol Hung 53(1–2): 95–104
Hasenohrl RU, Souza-Silva MA, Nikolaus S, Tomaz C, Brandao ML, Schwarting RK, Huston JP (2000) Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34(5): 272–280
Markowska AL, Mooney M, Sonntag WE (1998) Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience 87(3): 559–569
Wu HC, Chen KY, Lee WY, Lee EHY (1997) Antisense oligonucleotides to corticotropin-releasing factor impair memory retention and increase exploration in rats. Neuroscience 78(1): 147–153
Weninger SC, Dunn AJ, Muglia LJ, Dikkes P, Miczek KA, Swiergiel AH, Berridge CW, Majzoub JA (1999) Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci USA 96(14): 8283–8288
Heinrichs SC, Stenzel-Poore MP, Gold LH, Battenberg E, Bloom FE, Koob GF, Vale WW, Merlo Pich E (1996) Learning deficits in transgenic mice with central over-expression of corticotropinreleasing factor. Neuroscience 74(2): 303–311
Liebsch G, Landgraf R, Engelmann M, Loerscher P, Holsboer F (1999) Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisensc oligonucleotides into the rat brain. J Psychiatric Research 33(2): 153–163
Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale W, Gold LH (1999) Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res 835(1): 1–9
Pepin M-C, Pothier F, Barden N (1992) Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355: 725–728
Oitzl MS, Reichardt HM, Joels M, de Kloet ER (2001) Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc Natl Acad Sci USA 98(22): 12790–12795
Vallee M, Shen W, Heinrichs SC, Zorumski CF, Covey DF, Koob GF, Purdy RH (2001) Steroid structure and pharmacological properties determine the anti-amnesic effects of pregnenolone sulphate in the passive avoidance task in rats. Eur J Neurosci 14(12): 2003–2010
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Basel AG
About this chapter
Cite this chapter
Martinez, J.L., Thompson, K., McFadyen-Leussis, M.P., Heinrichs, S.C. (2004). Peptide and steroid hormone receptors as drug targets for enhancement of learning and memory performance. In: Buccafusco, J.J. (eds) Cognitive Enhancing Drugs. Milestones in Drug Therapy MDT. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7867-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7867-8_9
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9603-0
Online ISBN: 978-3-0348-7867-8
eBook Packages: Springer Book Archive